IntraBiotics' mission is to combine clinical development with recognized commercial expertise for the development and commercialization of emerging drugs and commercial products. To achieve that mission, we strive to deliver medical benefits to patients, to offer professional challenges for employees and to provide competitive returns for investors.
Key strategies include:
Focus on the development of the iseganan HCl product franchise. Iseganan is in phase III testing for the reduction in incidence and severity of oral mucositis and in phase II testing for the prevention of ventilator-associated pneumonia.
Expand our product portfolio through licensing and acquisitions of clinical candidates or commercial products.
Market products in the United States through a direct or contract sales force focused on major hospitals. Expand the sales reach by partnering with major, multinational pharmaceutical company to commercialize products in key European and Asian markets.
| Contact Details: |
| 1245 Terra Bella Avenue |
| Mountain View |
| CA |
| 94043 |
| United States of America |
| Tel: | (650) 526-6800 |
| Fax: | |
| Email: | |
| WWW: | www.apothogen.com/
|
|
Loading...
|
